<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>Pathogenetic significance of selectins in the progression of non-alcoholic fatty liver disease</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Гулхаё</mods:namePart><mods:namePart type="family">Рузимова</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases and represents a serious medical and social problem of modern healthcare. The growth of obesity, type 2 diabetes, metabolic syndrome, and insulin resistance contributes to the increase in the frequency of NAFLD worldwide. Modern concepts of the disease pathogenesis indicate a multifactorial nature of its development, including lipid metabolism disorders, chronic inflammation, oxidative stress, endothelial dysfunction, and immune disorders.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-06-10</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation house</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>